Jan 9, 2023 | Announcements, Compliance, News, No Surprises Act (NSA), Regulatory, Uncategorized
Higher fees and an extended reporting deadline are among the updated No Surprises Act (NSA) guidance and relief released by the Departments of Labor, Health and Human Services, and Treasury (the “Tri-Agencies”) on December 23. Specific updates include: An...
Jan 6, 2023 | Drug costs, Drugmakers, News, Prescription, Rx Costs
From Reuters: “Drugmakers including Pfizer Inc, GlaxoSmithKline PLC, Bristol Myers Squibb, AstraZeneca PLC and Sanofi SA plan to raise prices in the United States on more than 350 unique drugs in early January, according to data analyzed by healthcare research...
Jan 5, 2023 | Explanation of benefits (EOB), MedBen Access, Mobile App, Online Services
Less than 10% of plan members have made the switch to electronic explanations of benefits (EOBs) on MedBen Access… and there are benefits to going “paperless” that have nothing to do with saving trees (though that’s not a bad thing, either). By...
Jan 4, 2023 | Affordable Care Act, Cafeteria plans, Consumer-driven Health Plans, Health insurance exchanges, IRS
Once again, the IRS is seeking to increase access to federal Health Insurance Exchange coverage… this time, by offering greater flexibility to sponsors of cafeteria plans. As explained in Notice 2022-41, the IRS has expanded the change-in-status rules for...
Dec 27, 2022 | Alternative Reimbursement Strategies, Client Surveys, Kurt Harden, MedBen Rx, Prescription, Reference-Based Pricing, Regulatory
On behalf of our entire team, I wish you a Happy New Year and thank you for your continued business with MedBen. We often say that “MedBen Delivers,” and it’s a statement that covers a variety of factors such as plan design strategies, claims processing accuracy, and...
